Financing channel feed – Endpoints News

Financing channel feed

New SPAC submits plans for $130M IPO, as another raises $60M

3 years ago

IPO Friday: Hypertension drugmaker Mineralys maps out $192M Nasdaq debut

3 years ago

Prokarium raises $30M, pushes new bacteria immunotherapy for bladder cancer to clinic

3 years ago

Non-opioid drug developer snags PhIII funds; aTyr and Spruce line up capital

3 years ago

Swiss rare disease biotech withdraws IPO to update its Nasdaq plans

3 years ago

As clinical trials get more complex, software startup Faro bags $20M to help visualize them

3 years ago

Blood stem cell therapy maker Garuda nabs $62M

3 years ago

Oncolytic virus startup TILT raises €22M to advance cancer therapies

3 years ago

IgGenix sprints to clinic with peanut allergy candidate and additional $40M

3 years ago

Behind Friday's $161M IPO: A star scientist, GPCR drug discovery and a plan to challenge pharma in diabetes

3 years ago

Roivant, Vera seek $100M+ raises as they look to fund drug hopefuls

3 years ago

KKR healthcare vet Jim Momtazee’s investment firm closes $3.9B inaugural fund

3 years ago

GreenLight's mRNA vaccine nabs trial OK; Ratio reels in radiotherapy funds

3 years ago

Vector BioMed launches with $15M to produce backlogged CAR-T component

3 years ago

Alto Neuroscience bags $25M for four Phase II drugs

3 years ago

Pfizer-backed decentralized cooperative raises $4.1M to fund longevity research

3 years ago

Bristol Myers, Charles River join Series A funding for iVexSol

3 years ago

Profluent debuts to design proteins with machine learning in bid to move past 'AI sprinkled on top'

3 years ago

Grey Wolf reels in $49M to enter the clinic for new immunotherapy target

3 years ago

More data, more dollars: Three biotechs post offerings after trial readouts

3 years ago

Former DeepMind intern launches Atomic AI to 'parse' RNA structure for new small molecules

3 years ago

‘Siloing is just so outdated’: New $350M VC fund aims to digitize life sciences

3 years ago

Eli Lilly invests $450M to expand its North Carolina Research Triangle manufacturing site

3 years ago

CymaBay looks to raise $85M as liver drug's PhIII readout looms

3 years ago

First page Previous page 38 39 404142 43 44 Next page Last page